PHARM BREXIT

Manufacturers and suppliers of vital medicines and medical products say that the British authorities have not explained yet how their orders will be processed if the UK leaves the European Union at the end of October.

Some large pharmaceutical companies have decided to draw up their own plans for stockpiling of vital medicines while some are seeking to “book” seats in the government’s air and ferry schedule.

Nevertheless, despite repeated requests to the government about supply details, manufacturers and distributors still don't know from which ports the goods will be sent to, where they will arrive in the UK, the term and duration of delivery. This creates confusion and increases the risk of supply-chain disruptions and disturbance of the cold chain regime.

It should be noted that 37 million packages of medicines are imported to the UK every month from other European countries.

BaDM - We work for you!

Regional offices